Longboard Pharmaceuticals Inc. Gains 49.39%
Tue, Jan 03, 2023 at 06:58 PM
Longboard Pharmaceuticals Inc. (LBPH:NASDAQ) soared at $4.87, a gain of 49.4%. On Tue, Jan 03, 2023, LBPH:NASDAQ touched a New 2-Week High of $4.87. The stock appeared on our News Catalysts scanner on Mon, Dec 05, 2022 at 09:39 AM in the 'BIOTECH' category. From Tue, Dec 20, 2022, the stock recorded 37.50% Up Days and 11.11% Green Days
About Longboard Pharmaceuticals Inc. (LBPH:NASDAQ)
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases.
Top 10 Gainers:
- Jasper Therapeutics Inc. (JSPR:NASDAQ), 476.36%
- Lucira Health Inc. (LHDX:NASDAQ), 440.05%
- Horizon Global Corporation (HZN:NYSE), 342.39%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 84.08%
- Gelesis Holdings Inc. (GLS:NYSE), 79.06%
- Motorsport Games Inc. (MSGM:NASDAQ), 67.47%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 56.34%
- Viveve Medical, Inc. (VIVE:NASDAQ), 54.76%
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 49.39%
- iBio, Inc. (IBIO:NYSEMKT), 48.51%